Chemomab Therapeutics (CMMB) Income towards Parent Company (2017 - 2026)
Chemomab Therapeutics' Income towards Parent Company came in at $2.17 million for Q2 2026, up 5.3% from $2.06 million a year earlier.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Income towards Parent Company (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Chemomab Therapeutics reported Income towards Parent Company of $4.01 million, down 22.6% year-over-year; for FY2025, it was $9 million, down 35.5% from FY2024.
- Income towards Parent Company has declined in each of the last three years.
- Going back by year, Income towards Parent Company was $13.95 million in FY2024 (-42.4%), $24.22 million in FY2023 (-12.4%), $27.65 million in FY2022 (+121.6%) and $12.48 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Income towards Parent Company since Q4 2024.
- Year-over-year, Income towards Parent Company increased in 1 of the last five quarters, with an average decline of 21.9%.
- The fastest year-over-year change in Income towards Parent Company over five years came in Q2 2023 (growth of 28.8%), and the weakest in Q4 2023 (a decline of 58.7%).
- Business Quant data shows CMMB's Income towards Parent Company at -$1.77 million (Q1 2026), $1.87 million (Q4 2025) and $1.74 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Chemomab Therapeutics | 10.28 Mn | 10.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | -1.77 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | -3.32 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | -3.63 Mn |
| Mar 31, 2024 | -3.87 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 7.97 Mn |
| Mar 31, 2023 | -8.75 Mn |
| Dec 31, 2022 | 8.27 Mn |
| Sep 30, 2022 | 8.08 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | -5.10 Mn |
| Dec 31, 2021 | 19.92 Mn |
| Sep 30, 2021 | -2.97 Mn |
API Access
Chemomab Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();